Korean J Physiol Pharmacol.  1998 Aug;2(4):411-417.

Mediation of intracellular Ca2+ in the phospholipase A2-induced cell proliferation in human neuroblastoma cells

Affiliations
  • 1Department of Physiology, College of Pharmacy, Yeungnam University, Kyongsan 712-749, Korea.
  • 2Department of Physiology, College of Medicine, Kwandong University, Kangnung 210-701, Korea.

Abstract

The role of phospholipase A2 (PLA2) in tumor cell growth was investigated using SK-N-MC human neuroblastoma cells. 4-Bromophenacyl bromide (BPB) and mepacrine (Mep), known PLA2 inhibitors, suppressed growth of the tumor cells in a dose-dependent manner without a significant cytotoxicity. Melittin (Mel), a PLA2 activator, enhanced the cell growth in a concentration-dependent fashion. The growth-enhancing effects of Mel were significantly reversed by the co-treatment with PLA2 inhibitors. In addition, Mel induced intracellular Ca2+ release from internal stores like as did serum, a known intracellular Ca2+ agonist in the tumor cells. Intracellular Ca2+ release induced by these agonists was significantly blocked by PLA2 inhibitors at growth-inhibitory concentrations. Arachidonic acid (AA), a product of the PLA2-catalyzed reaction, induced cell growth enhancement and intracellular Ca2+ release. These effects of AA were significantly blocked by BAPTA/AM, an intracellular Ca2+ chelator. Taken together, these results suggest that the modulation of PLA2 activity may be one of the regulatory mechanisms of cell growth in human neuroblastoma cells. Intracellular Ca2+ may act as a key mediator in the PLA2-induced growth regulation.

Keyword

Phospholipase A2; Human neuroblastoma cells; Cell proliferation; Intracellular Ca2+

MeSH Terms

Arachidonic Acid
Cell Proliferation*
Humans*
Melitten
Negotiating*
Neuroblastoma*
Phospholipases A2
Phospholipases*
Quinacrine
Arachidonic Acid
Melitten
Phospholipases
Phospholipases A2
Quinacrine
Full Text Links
  • KJPP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr